We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

YM BioSciences Announces Pivotal Preclinical Efficacy Data for the JAK1/2 inhibitor CYT387

News   Apr 21, 2010

 
YM BioSciences Announces Pivotal Preclinical Efficacy Data for the JAK1/2 inhibitor CYT387
 
 
 

RELATED ARTICLES

Aging in Older Mice Delayed by Giving Enzyme From Younger Mice

News

New research has identified a novel approach to staving off the detrimental effects of aging in mice.

READ MORE

Human Blood-Brain Barrier Chip Aids Development of Brain-targeting Drugs

News

A microfluidic organ chip model of the human blood-brain barrier, that recapitulates in vivo barrier functions, offers a new preclinical tool for development of brain-targeting therapeutics.

READ MORE

Quality Assurance Step in Gene Expression Clarified in Yeast

News

Removal of introns from pre-mRNAs is an essential step in eukaryotic gene expression. Using yeast, researchers provided new insights on this evolutionarily conserved quality assurance step.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE